- Home
- KPTI vs AOMR Comparison
KPTI vs AOMR Comparison
Compare KPTI & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | AOMR |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | United States | United States |
| Employees | 228 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.8M | 218.7M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KPTI | AOMR |
|---|---|---|
| Price | $8.63 | $8.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $16.00 | $11.08 |
| AVG Volume (30 Days) | ★ 403.3K | 60.9K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.18% |
| EPS Growth | N/A | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.36 | $1.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.65 | $7.96 |
| 52 Week High | $10.99 | $10.21 |
Technical Indicators
Market Signals| Indicator | KPTI | AOMR |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 50.09 |
| Support Level | $8.11 | $8.64 |
| Resistance Level | $9.00 | $8.91 |
| Average True Range (ATR) | 0.58 | 0.18 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 33.12 | 26.24 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.